Cluzeau, T., Dumas, P. Y., Montesinos, P., Ciolli, G., Berthon, C., Ferrara, F., Venditti, A., Pérez-Simón, J. A., Calbacho, M., Noppeney, R., Lunghi, M., Cattaneo, C., Pane, F., Lanza, F., Burgues, J. M. B., Isidori, A., Floisand, Y., Jain, V., Wang, E. (2025). Crenolanib plus salvage chemotherapy improves outcomes in FLT3-mutant and NPM1 co-mutated relapsed/ refractory (R/R) Acute Myeloid Leukemia (AML): Results from a randomized, placebo-controlled, double-blind trial. Blood. https://doi.org/10.1182/blood-2025-767